Dissecting and Evaluating the Therapeutic Targets of Coptis Chinensis Franch in the Treatment of Urinary Tract Infections Induced by Escherichia coli
Coptis chinensis Franch (CCF) is extensively used in the treatment of inflammatory-related diseases. Accumulating studies have previously demonstrated the anti-inflammatory properties of CCF, yet data on its exact targets against urinary tract infections (UTIs) remain largely unknown. Therefore, the...
Main Authors: | Zhenglin Chang, Jinhu Zhang, Min Lei, Zheng Jiang, Xiangkun Wu, Yapeng Huang, Zhican He, Yuyan Zhang, Shujue Li, Xiaolu Duan, Wenqi Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.794869/full |
Similar Items
-
Transcriptome analyses provide insights into the difference of alkaloids biosynthesis in the Chinese goldthread (Coptis chinensis Franch.) from different biotopes
by: Hanting Chen, et al.
Published: (2017-05-01) -
Isoquinoline Alkaloids from <i>Coptis chinensis</i> Franch: Focus on Coptisine as a Potential Therapeutic Candidate against Gastric Cancer Cells
by: Sylwia Nakonieczna, et al.
Published: (2022-09-01) -
Effects of growing Coptis chinensis Franch in the natural understory vs. under a manmade scaffold on its growth, alkaloid contents, and rhizosphere soil microenvironment
by: Yu Wang, et al.
Published: (2022-07-01) -
Modulation of gut microbiota by berberine and decocted Coptis chinensis Franch. in a high-fat diet-induced metabolic syndrome rat model
by: Ti Huang, et al.
Published: (2017-04-01) -
Systematic review and meta-analysis of Coptis chinensis Franch.-containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus
by: Linlin Pan, et al.
Published: (2022-09-01)